Introduction:Basic information about CAS 42399-49-5|(2S-cis)-(+)-2,3-Dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | (2S-cis)-(+)-2,3-Dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one |
|---|
| CAS Number | 42399-49-5 | Molecular Weight | 301.360 |
|---|
| Density | 1.3±0.1 g/cm3 | Boiling Point | 545.4±50.0 °C at 760 mmHg |
|---|
| Molecular Formula | C16H15NO3S | Melting Point | 203-206 °C(lit.) |
|---|
| MSDS | / | Flash Point | 283.7±30.1 °C |
|---|
Names
| Name | (2S-cis)-(+)-2,3-Dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one |
|---|
| Synonym | More Synonyms |
|---|
Chemical & Physical Properties
| Density | 1.3±0.1 g/cm3 |
|---|
| Boiling Point | 545.4±50.0 °C at 760 mmHg |
|---|
| Melting Point | 203-206 °C(lit.) |
|---|
| Molecular Formula | C16H15NO3S |
|---|
| Molecular Weight | 301.360 |
|---|
| Flash Point | 283.7±30.1 °C |
|---|
| Exact Mass | 301.077271 |
|---|
| PSA | 83.86000 |
|---|
| LogP | 2.08 |
|---|
| Vapour Pressure | 0.0±1.5 mmHg at 25°C |
|---|
| Index of Refraction | 1.635 |
|---|
| InChIKey | LHBHZALHFIQJGJ-CABCVRRESA-N |
|---|
| SMILES | COc1ccc(C2Sc3ccccc3NC(=O)C2O)cc1 |
|---|
Safety Information
| Hazard Codes | Xi:Irritant; |
|---|
| Risk Phrases | R36/37/38 |
|---|
| Safety Phrases | S26-S36 |
|---|
| WGK Germany | 3 |
|---|
| HS Code | 2934999090 |
|---|
Customs
| HS Code | 2934999090 |
|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|---|
Synonyms
| EINECS 255-799-0 |
| HYDROXY LACTAM |
| MFCD01321316 |
| (2S-CIS)-(+)-DIHYDRO-3-OH-2-(4-MEO-PH)-1,5-BENZOTHIAZEPIN-4(5H)-ONE |
| (2S-cis)-2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one |
| Des[3-Acetyl-5-(2-dimethylamino)ethyl] Diltiazem |
| (2S,3S)-3-Hydroxy-2-(4-methoxyphenyl)-2,3-dihydrobenzo[b][1,4]thiazepin-4(5H)-one |
| (2S,3S)-(+)-2,3-Dihydro-3-hydroxy-2-(4-Methoxyphenyl)-1,5-benzothiazepin-4(5H)-one |
| (+)-cis-(2S,3S)-2-(4-methoxyphenyl)-3-hydroxy-2,3-dihydro-5H-1,5-benzothiazepin-4-one |
| 1,5-Benzothiazepin-4(5H)-one, 2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-, (2S,3S)- |
| (2S,3S)-DHMB |
| 5-benzothiazepin-4(5h)-one,2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-(2s-c |
| (+)-cis-(2S,3S)-2,3-dihydro-3-hydroxy-2-(4'-methoxyphenyl)-1,5-benzothiazepin-4-[5H]-one |
| (2S,3S)-3-Hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one |
| (2S,3S)-3-Hydroxy-2-(4-methoxy-phen; yl)-2,3-dihydro-5H-benzo[b][1,4]thi; azepin-4-one |
| CIS-2,3-DIHYDRO-3-HYDROXY-2-(4-METHOXYPHENYL)-1,5-BENZOTHIAZEPIN-4(5H)-ONE |
| (2S-CIS)-2,3-DIHYDRO-3-HYDROXY-2-(4-METHOXYPHENYL)-1,5-BENZOTHIAZEPIN |
| (+)-(2S,3S)-2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one |
| (+)-cis-(2S,3S)-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydrobenzo[b][1,4]thiazepin-4(5H)-one |